Healthcare trends

Global Acute Myeloid Leukemia Market Information; by Disease Type (Myeloblastic, Promyeloctic, Myelomonocytic, Monocytic, Erythroleukemia, Megakaryocytic); by Treatment (Chemotherapy (Induction, Post Remission), Hematopoietic Stem Cell Transplantation) - Forecast to 2023 Market Highlights Market Research Futures (MRFR) report on the global acute myeloid leukemia (AML) treatment is expected to grow at a moderate CAGR of 5.3% over the forecast period of 2017 to 2023 and culminate in a value above USD 1 Bn by the end of the assessment period. This type of cancer is comparatively rare and progresses at a rapid pace thus creating significant demand for effective treatment and diagnostic options. Increasing diagnoses of AML are due to exposure to carcinogenics which are present everywhere. Changing lifestyles have given rise to unhealthy habits which lead to cancer. AML can also be passed genetically, and increased prevalences of cancer combined with the growing population ...

Market Research Future published a research report on Acute Myeloid Leukemia Treatment Market Research Report - Global Forecast To 2023. Report gives a clear picture of current market scenario which includes past and estimated future market size. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions. Market Research Futures (MRFR) report on the global acute myeloid leukemia (AML) treatment is expected to grow at a moderate CAGR of 5.3% over the forecast period of 2017 to 2023 and culminate in a value above USD 1 Bn by the end of the assessment period. This type of cancer is comparatively rare and progresses at a rapid pace thus creating significant demand for effective treatment and diagnostic options. Market Segmentation The global  acute myeloid leukemia treatment market  is segmented on the basis of disease type, treatment, and region. By disease type, ...